NCT05999773View on ClinicalTrials.gov

SGLT-2 Inhibitors in the Treatment of Ascites

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

July 15, 2025

Study Completion Date

December 31, 2026

Conditions
Ascites HepaticCirrhosis, LiverDiabete Type 2
Interventions
DRUG

SGLT2 inhibitor

Start of SGLT-2 inhibitors to treat diabetes according diabetology indications.

Trial Locations (2)

90100

RECRUITING

Internal Medicine Unit, V. Cervello Hospital, Palermo

90127

RECRUITING

Department of Internal Medicine, University Hospital of Palermo, Palermo

All Listed Sponsors
collaborator

Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

OTHER

lead

University of Palermo

OTHER